Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia

被引:69
|
作者
Singh, Rajenda S. [1 ,9 ]
Grayson, Wayne [2 ,3 ]
Redston, Mark [4 ,5 ]
Diwan, A. Hafeez [1 ,9 ]
Warneke, Carla L. [7 ]
Mckee, Phillip H. [4 ,5 ]
Lev, Dina [10 ]
Lyle, Stephen [6 ]
Calonje, Eduardo [8 ]
Lazar, Alexander J. F. [1 ,9 ,10 ]
机构
[1] Univ Witwatersrand, Sect Dermatopathol, Dept Pathol, Johannesburg, South Africa
[2] Univ Witwatersrand, Sch Pathol, Div Anat Pathol, Johannesburg, South Africa
[3] Natl Hlth Lab Serv, Johannesburg, South Africa
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[6] Univ Massachusetts, Med Ctr, Dept Canc Biol, Worcester, MA USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Appl Math & Biostat, Houston, TX 77030 USA
[8] St Thomas Hosp, St Johns Inst Dermatol, Dept Dermatopathol, London, England
[9] Univ Witwatersrand, Sect Dermatopathol, Dept Dermatol, Johannesburg, South Africa
[10] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
关键词
sebaceous neoplasia; mismatch repair deficiency; Muir-Torre syndrome; cystic; keratoacanthoma;
D O I
10.1097/PAS.0b013e31815b0cc2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cutaneous sebaceous neoplasia is known to exhibit a high degree of DNA mismatch repair (MMR) deficiency leading to microsatellite instability and these tumors can be markers of the Muir-Torre syndrome and internal malignancy. Other tumors, such as colonic carcinoma, show tendencies toward particular histologic features and sites of involvement correlating with MMR deficiency. There are few comprehensive studies of unselected cutaneous sebaceous neoplasms. To address this gap in knowledge, we examined 94 sebaceous neoplasms from 92 patients and 17 sebaceous hyperplasia controls using immunohistochemistry for MLH1, MSH2, and MSH6. Our results indicate that MMR deficiency is significantly associated with anatomic location (more frequently in the trunk and extremities as compared with head and neck), tumor type (more often in adenoma compared with carcinoma within the head and neck region), and architecture (keratoacanthomalike). No correlation between cystic change and MMR deficiency was noted. Cutaneous sebaceous neoplasia has tendencies toward certain tumor types and anatomic distribution based on MMR status analogous to that seen in colonic carcinomas and other tumors. These may be helpful indicators for further workup for the Muir-Torre syndrome.
引用
收藏
页码:936 / 942
页数:7
相关论文
共 50 条
  • [31] Immunohistochemical (IHC) detection of DNA mismatch repair (MMR) proteins in sebaceous neoplasms: Patterns and clinical significance
    Oria, L.
    Busam, K.
    Mecca, P.
    Tang, L.
    Klimstra, D.
    Shia, J.
    LABORATORY INVESTIGATION, 2008, 88 : 368A - 368A
  • [32] DNA mismatch repair status and site of tumor recurrence in state II and III colon cancers treated in 5-fluorouracil-based adjuvant therapy trials
    Sinicrope, F.
    Foster, N. R.
    Sargent, D. J.
    Gallinger, S.
    Benatti, P.
    Marsoni, S.
    Monges, G.
    Labianca, R.
    O'Connell, M. J.
    Allegra, C. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Clinicopathologic significance of DNA mismatch repair protein status in endometrial cancer
    Kim, Ju-Hyun
    Kwon, Byung-Su
    Kim, Hyojin
    Suh, Dong Hoon
    Kim, Kidong
    Kim, Yong Beom
    No, Jae Hong
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2022, 61 (03): : 415 - 421
  • [34] Immunohistochemical (IHC) detection of DNA mismatch repair (MMR) proteins in sebaceous neoplasms: Patterns and clinical significance
    Orta, L.
    Busam, K.
    Mecca, P.
    Tang, L.
    Klimstra, D.
    Shia, J.
    MODERN PATHOLOGY, 2008, 21 : 368A - 368A
  • [35] The DNA Mismatch Repair System in Sebaceous Tumors: An Update on the Genetics and Workup of Muir-Torre Syndrome
    Dany, Mohammed
    CUTIS, 2020, 105 (03): : E34 - E37
  • [36] Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome
    Jessup, Chad J.
    Redston, Mark
    Tilton, Erin
    Reimann, Julie D. R.
    HUMAN PATHOLOGY, 2016, 49 : 1 - 9
  • [37] Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers
    Kim, Soyoun Rachel
    Tone, Alicia
    Kim, Raymond
    Cesari, Matthew
    Clarke, Blaise
    Eiriksson, Lua
    Hart, Tae
    Aronson, Melyssa
    Holter, Spring
    Lytwyn, Alice
    Maganti, Manjula
    Oldfield, Leslie
    Gallinger, Steven
    Bernardini, Marcus Q.
    Oza, Amit M.
    Djordjevic, Bojana
    Lerner-Ellis, Jordan
    Van de Laar, Emily
    Vicus, Danielle
    Pugh, Trevor J.
    Pollett, Aaron
    Ferguson, Sarah Elizabeth
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (12) : 1951 - 1958
  • [38] Tumor mutation burden, DNA mismatch repair status and checkpoint immunotherapy markers in primary and relapsed malignant rhabdoid tumors
    Abro, Brooj
    Kaushal, Madhurima
    Chen, Ling
    Wu, Robert
    Dehner, Louis P.
    Pfeifer, John D.
    He, Mai
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (06)
  • [39] Determining the site and nature of DNA mutations with the cloned MutY mismatch repair enzyme
    Xu, JF
    Yang, QP
    Chen, JYJ
    vanBaalen, MR
    Hsu, IC
    CARCINOGENESIS, 1996, 17 (02) : 321 - 326
  • [40] Mismatch repair status between primary colorectal tumor and metastatic tumor, a retrospective consistent study
    Wang, Zheng
    Tang, Xiaoli
    Wu, Xiaoqing
    Yang, Meiyuan
    Wang, Daorong
    BIOSCIENCE REPORTS, 2019, 39